PI
REGN icon

PEAK6 Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

PEAK6 Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$11.6M Buy
11,000
+600
+6% +$668K 0.03% 500
2024
Q2 		$10.9M Sell
10,400
-3,600
-26% -$3.49M 0.03% 454
2024
Q1 		$13.5M Sell
14,000
-17,600
-56% -$16.7M 0.04% 402
2023
Q4 		$27.8M Buy
31,600
+5,200
+20% +$4.28M 0.1% 167
2023
Q3 		$21.7M Sell
26,400
-4,300
-14% -$3.38M 0.1% 167
2023
Q2 		$22.1M Sell
30,700
-10,200
-25% -$7.86M 0.1% 165
2023
Q1 		$33.6M Buy
40,900
+24,500
+149% +$18.5M 0.16% 100
2022
Q4 		$11.8M Sell
16,400
-15,000
-48% -$11.1M 0.07% 307
2022
Q3 		$21.6M Sell
31,400
-79,900
-72% -$50.3M 0.09% 199
2022
Q2 		$69.7M Buy
111,300
+400
+0.4% +$260K 0.13% 110
2022
Q1 		$77.5M Sell
110,900
-25,400
-19% -$16.1M 0.16% 105
2021
Q4 		$86.1M Buy
136,300
+38,200
+39% +$23.5M 0.18% 87
2021
Q3 		$59.4M Buy
98,100
+37,336
+61% +$23.2M 0.13% 121
2021
Q2 		$37.5M Sell
60,764
-436
-0.7% -$221K 0.09% 202
2021
Q1 		$29M Buy
61,200
+9,700
+19% +$4.72M 0.07% 247
2020
Q4 		$24.9M Buy
51,500
+7,400
+17% +$3.99M 0.05% 334
2020
Q3 		$24.7M Buy
44,100
+1,500
+4% +$910K 0.06% 277
2020
Q2 		$26.6M Sell
42,600
-4,500
-10% -$2.55M 0.09% 197
2020
Q1 		$23M Sell
47,100
-21,100
-31% -$8.7M 0.13% 136
2019
Q4 		$25.6M Buy
68,200
+22,100
+48% +$7.44M 0.13% 142
2019
Q3 		$12.8M Sell
46,100
-14,800
-24% -$4.38M 0.08% 280
2019
Q2 		$19.1M Buy
60,900
+16,800
+38% +$5.59M 0.13% 164
2019
Q1 		$18.1M Buy
44,100
+400
+0.9% +$165K 0.11% 192
2018
Q4 		$16.3M Sell
43,700
-4,400
-9% -$1.61M 0.1% 190
2018
Q3 		$19.4M Buy
+48,100
New +$18.3M 0.08% 235

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PEAK6 Investments's REGN Position: Q3 2024 in Review

PEAK6 Investments held its Regeneron Pharmaceuticals (REGN) position steady in Q3 2024 at 2 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #3314.

PEAK6 Investments first reported a position in REGN in Q4 2018 and has held it in 20 quarters since. The position peaked at $12.5M in Q1 2021. 1,388 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • PEAK6 Investments held 2 shares of Regeneron Pharmaceuticals worth $1.73K as of Q3 2024.
  • PEAK6 Investments left its Regeneron Pharmaceuticals share count unchanged in Q3 2024.
  • Regeneron Pharmaceuticals made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #3314 holding.
  • PEAK6 Investments first reported a position in Regeneron Pharmaceuticals in Q4 2018 and has held it in 20 quarters since.
  • PEAK6 Investments's Regeneron Pharmaceuticals position peaked at $12.5M in Q1 2021.
  • 1,388 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.